JMP Securities Downgrades Proteon Therapeutics (PRTO) to Market Perform

March 28, 2019 10:58 AM

JMP Securities analyst Jason Butler downgraded Proteon Therapeutics (NASDAQ ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found